Global Alzheimer's Platform Foundation Develops Consortium

North America - United States

The Global Alzheimer's Platform (GAP) Foundation established a consortium of public and private stakeholders, including leading pharmaceutical companies, to develop the infrastructure to recruit participants for large scale Alzheimer's clinical trials. GAP's efforts also included establishing a global registry and a network of certified, high-performance clinical trial sites.

Faegre Baker Daniels served as counsel on the development of the consortium.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.